Retatrutida SENO Polvo Liofilizado Precio al por mayor al por mayor

Descripción

Multi-Receptor Agonist Péptido for Metabolic & Endocrine Research

Retatrutide is a next-generation synthetic research peptide investigated for its triple receptor agonist activity involving GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Its multi-pathway mechanism has made it an important compound in advanced metabolic, obesity, endocrine, and receptor-signaling research models.

SENO supplies high-purity Retatrutide lyophilized powder in multiple research specifications ranging from 5mg to 100mg per vial set. Each batch is manufactured using automated solid-phase peptide synthesis (SPPS), purified by preparative HPLC, and verified using analytical mass spectrometry.

Available specifications:

  • RT5 — 5mg × 10 vials
  • RT10 — 10mg × 10 vials
  • RT15 — 15mg × 10 vials
  • RT20 — 20mg × 10 vials
  • RT30 — 30mg × 10 vials
  • RT40 — 40mg × 10 vials
  • RT50 — 50mg × 10 vials
  • RT60 — 60mg × 10 vials
  • RT100 — 100mg × 10 vials

This peptide is supplied exclusively for laboratory research applications.


¿Qué es la retatrutida?

Retatrutide is a synthetic multi-receptor agonist peptide designed to simultaneously target:

  • GLP-1 receptors
  • GIP receptors
  • glucagon receptors

Its molecular structure was developed to investigate how combined receptor activation influences:

  • metabolic regulation
  • gasto energético
  • glucose metabolism
  • hormonal signaling
  • receptor crosstalk mechanisms

Unlike single-pathway peptide compounds, Retatrutide is studied for its ability to activate multiple metabolic signaling systems simultaneously, making it highly relevant in obesity, endocrine, and receptor pharmacology research.

The peptide is typically supplied as a white lyophilized powder to preserve structural stability during storage and transport.


Aplicaciones de la investigación

Retatrutide is widely used in advanced laboratory investigations involving:

  • GLP-1 receptor pathway studies
  • GIP receptor signaling research
  • glucagon receptor modulation analysis
  • metabolic pathway investigations
  • obesity and energy balance models
  • endocrine system research
  • receptor-binding affinity studies
  • peptide pharmacodynamics analysis
  • multi-hormonal signaling experiments
  • preclinical metabolic research

Its triple agonist profile makes Retatrutide particularly valuable in studies exploring synergistic receptor interactions and integrated metabolic regulation.


Fórmula molecular

C221H342N46O68C_{221}H_{342}N_{46}O_{68}


Peso molecular

4837.4 g/mol4837.4\ g/mol


Número CAS

ParámetroDetalles
Nombre del productoRetatrutida
Número CAS2381089-83-2
Tipo molecularPéptido sintético
FormularioPolvo liofilizado
Pureza≥98% (HPLC verified)

Especificaciones del producto

Código del productoEspecificaciónFormulario
RT55mg × 10 vialsPolvo liofilizado
RT1010mg × 10 vialsPolvo liofilizado
RT1515mg × 10 vialsPolvo liofilizado
RT2020mg × 10 vialsPolvo liofilizado
RT3030mg × 10 vialsPolvo liofilizado
RT4040mg × 10 vialsPolvo liofilizado
RT5050mg × 10 vialsPolvo liofilizado
RT6060mg × 10 vialsPolvo liofilizado
RT100100mg × 10 vialsPolvo liofilizado

Mecanismo de acción

Retatrutide is investigated as a triple receptor agonist capable of interacting with:

  • GLP-1 receptors
  • GIP receptors
  • glucagon receptors

This multi-target mechanism is studied for its effects on metabolic signaling networks and energy homeostasis.

Primary research interests include:

GLP-1 Receptor Activity

Associated with investigations into:

  • glucose regulation
  • insulin signaling
  • appetite-related pathways

GIP Receptor Activity

Studied in relation to:

  • incretin biology
  • metabolic modulation
  • hormonal signaling coordination

Glucagon Receptor Activity

Researched for potential influence on:

  • gasto energético
  • lipid metabolism
  • hepatic metabolic pathways

The simultaneous activation of these receptor systems makes Retatrutide distinct from traditional single-pathway metabolic peptides.


Solubilidad

Retatrutide is generally soluble in:

  • agua estéril
  • bacteriostatic water
  • solución salina tamponada con fosfato (PBS)
  • selected research buffers

Solubility characteristics may vary depending on:

  • preparation concentration
  • pH conditions
  • temperature
  • experimental protocol

Researchers commonly prepare aliquots to reduce repeated freeze-thaw exposure after reconstitution.


Recomendaciones de almacenamiento

Para una estabilidad óptima del péptido:

  • Store lyophilized powder at -20°C
  • Protect from direct light and moisture
  • Avoid repeated temperature fluctuations
  • Use sterile handling procedures during preparation

Después de la reconstitución:

  • Conservar a 2-8°C para uso a corto plazo
  • Minimizar los ciclos de congelación y descongelación
  • Use freshly prepared solutions whenever possible

Información sobre estabilidad

Retatrutide is supplied in lyophilized form to improve long-term structural stability and reduce degradation risk during transport and storage.

Peptide stability may be affected by:

  • oxidación
  • hidrólisis
  • temperature exposure
  • pH conditions
  • ciclos repetidos de congelación y descongelación
  • contaminación microbiana

Lyophilization helps maintain peptide integrity by reducing moisture exposure during storage.


Estudios de investigación e interés científico

Retatrutide has become a major subject of interest in metabolic and endocrine research due to its simultaneous receptor-targeting design.

Current areas of laboratory investigation include:

  • integrated hormonal signaling
  • metabolic regulation models
  • obesity-related pathway research
  • glucose homeostasis studies
  • farmacología de receptores
  • peptide-receptor interaction analysis
  • energy expenditure mechanisms

Its multi-receptor mechanism has expanded scientific interest in combination pathway modulation approaches within peptide research.


Fabricación y control de calidad

SENO manufactures Retatrutide using automated solid-phase peptide synthesis (SPPS) platforms under controlled laboratory conditions.

El flujo de trabajo de producción incluye:

  • pharmaceutical-grade amino acid sourcing
  • automated peptide chain elongation
  • controlled deprotection and coupling cycles
  • preparative HPLC purification
  • analytical mass spectrometry confirmation
  • sterile lyophilization procedures

Each production batch undergoes analytical verification to support:

  • purity consistency
  • peptide identity confirmation
  • integridad estructural
  • batch reproducibility

This controlled manufacturing process helps ensure reliable performance in sensitive laboratory experiments.


COA (Certificado de análisis)

La documentación analítica puede incluir:

  • batch number
  • peptide identity
  • HPLC purity analysis
  • mass spectrometry verification
  • inspección de aspecto
  • storage recommendations
  • fecha de fabricación

COA documentation supports laboratory traceability and internal research quality-control procedures.


Verificación por HPLC y espectrometría de masas

Each batch undergoes analytical testing using:

  • Cromatografía líquida de alto rendimiento (HPLC)
  • Espectrometría de masas (EM)

These analytical methods help verify:

  • peptide purity
  • identidad molecular
  • consistencia de los lotes
  • impurity profile assessment

HPLC chromatograms and MS data may be available for research documentation purposes.


Guía de reconstitución

Procedimiento de laboratorio recomendado

  1. Allow vial to reach room temperature before opening.
  2. Prepare sterile water or appropriate research buffer.
  3. Slowly inject solvent along the vial wall.
  4. Avoid direct high-pressure impact on the lyophilized powder.
  5. Gently swirl until fully dissolved.
  6. Do not shake vigorously.
  7. Aliquot prepared solution when possible.
  8. Store prepared solutions under recommended conditions.

Reconstitution concentrations should be optimized according to individual research protocols.


Precauciones de manipulación

  • Para uso exclusivo en investigación de laboratorio
  • No destinado a la administración humana o veterinaria
  • Utilizar los EPI de laboratorio adecuados
  • Handle using sterile technique
  • Evitar la contaminación durante la preparación
  • Dispose of materials according to institutional regulations

Información de envío

  • Worldwide shipping via FedEx or equivalent courier
  • Supplied as lyophilized powder for improved transport stability
  • Secure protective packaging
  • Designed for international laboratory shipping workflows

Preguntas más frecuentes (FAQ)

What is Retatrutide used for in research?

Retatrutide is commonly studied in metabolic, endocrine, receptor-signaling, and obesity-related laboratory investigations due to its triple receptor agonist profile.


Why is Retatrutide considered a triple agonist?

The peptide is designed to interact with GLP-1, GIP, and glucagon receptors simultaneously, allowing researchers to investigate integrated metabolic signaling pathways.


How is Retatrutide supplied?

SENO supplies Retatrutide as a white lyophilized powder in multiple vial specifications ranging from RT5 to RT100.


Why is the peptide lyophilized?

Lyophilization helps improve peptide stability during storage and international shipping by reducing moisture-related degradation.


How should Retatrutide be stored?

Lyophilized peptide should generally be stored at -20°C. Reconstituted solutions are typically stored at 2–8°C and used within a short period.


Is this product intended for medical or therapeutic use?

No. Retatrutide supplied by SENO is strictly intended for laboratory research applications only and is not approved for human or veterinary use.